One-year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes.

Zoltán J Taybani, Balázs Bótyik,András Gyimesi,Mónika Katkó,Tamás Várkonyi

Endocrinology, diabetes & metabolism（2023）

引用 0|浏览11

暂无评分

摘要

Insulin treatment simplification with IDegLira in selected patients with type 2 diabetes is safe, maintains adequate glycaemic control and is associated with weight loss over 12 months.

查看译文

关键词

IDegLira,diabetes,overtreatment,simplification

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要